US · Healthcare

Actinogen Medical Limited (ATGGF)

Biotechnology

Actinogen Medical Limited (ATGGF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ATGGF

P/E ratio

18.00

Actinogen Medical Limited (ATGGF) — FAQ

What is ATGGF's P/E ratio?

The price-to-earnings (P/E) ratio for Actinogen Medical Limited (ATGGF) is 18.00 (data as of 2026-03-23).

Does Actinogen Medical Limited pay a dividend?

Dividend yield is not available in the current snapshot for Actinogen Medical Limited (ATGGF). Check the MyAverix Finance app for the latest dividend data.

What sector is Actinogen Medical Limited in?

Actinogen Medical Limited (ATGGF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is ATGGF listed on?

ATGGF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)